ICD-10 Specific code C50: Malignant neoplasm of breast

Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.

Translations

Language Translation
Flag for English language  English Malignant neoplasm of breast
Flag for French language  French Tumeur maligne du sein

Hierarchical position

Level Code Title
1 II Neoplasms
2 C00-C97 Malignant neoplasms
3 C50 Malignant neoplasm of breast

Contents

Code Title
C50.0 Malignant neoplasm: Nipple and areola
C50.1 Malignant neoplasm: Central portion of breast
C50.2 Malignant neoplasm: Upper-inner quadrant of breast
C50.3 Malignant neoplasm: Lower-inner quadrant of breast
C50.4 Malignant neoplasm: Upper-outer quadrant of breast
C50.5 Malignant neoplasm: Lower-outer quadrant of breast
C50.6 Malignant neoplasm: Axillary tail of breast
C50.8 Malignant neoplasm: Overlapping lesion of breast
C50.9 Malignant neoplasm: Breast, unspecified

Indicated medicines

Active Ingredient Description
Eribulin mesylate

Eribulin is a microtubule dynamics inhibitor belonging to the halichondrin class of antineoplastic agents. It is a structurally simplified synthetic analogue of halichondrin B, a natural product isolated from the marine sponge Halichondria okadai.

Ifosfamide

Ifosfamide is an antineoplastic, a cytotoxic alkylating agent. It is a prodrug and shows no in vitro cytotoxic activity until activated by microsomal enzymes. The cytotoxic activity of ifosfamide (alkylation of the nucleophilic centres in the cells) is associated with the activated oxazaphosphorine ring hydroxylated at the C4 atom which interacts with DNA-DNA cross linking. This activity manifests itself by blocking the late S and early G2 phases of the cell cycle.